ADXN
Addex Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ADXN Filings
Filing Date
Form Description
Form Type
2025-12-04
Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Transcript
Earnings Call
2025-12-04 · Earnings Call
Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Transcript
2025-12-04
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-12-04 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-19
Form F-3 - Registration statement by foreign private issuers
2025-11-19 ·
Form F-3 - Registration statement by foreign private issuers
2025-10-29
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-29 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-09-30 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-06-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-06-30 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-06-25
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-06-25 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-06-23
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-06-23 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-06-20
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-06-20 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
